Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.

Also called NCT06591377

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06591377
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06591377. Randomized; double masking; primary purpose treatment. Start 2024-08-10 (actual); primary completion 2025-09-19 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
Intervention (Drug)
Ticagrelor 90 MG
Intervention (Drug)
Cilostazol 100 MG
Intervention (Drug)
Aspirin 75mg
Intervention (Drug)
Aspirin 75mg
Lead sponsor
Kafrelsheikh University (class: other)
Collaborator
El-Sahel Teaching Hospital (class: other government)

Record details

Record id
cardio:ct-nct06591377
Content hash
6abc055b4b510980d5818911cb7f642812a5a214641e0afbe3ffcd2b558dfa3a